Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community
Evaluation of Pharmacy-Based HIV Testing in a High-Risk New York City Community
复制标题
DOI：
10.1089/apc.2015.0017
复制
发表时间：
2015-08-01
影响因子：
4.9
通讯作者：
Lewis, Crystal Fuller
中科院分区：
文献类型：
--
作者：
Amesty, Silvia;Crawford, Natalie D.;Lewis, Crystal Fuller
黑人/拉美裔美国人接受艾滋病毒检测的机会有限。我们检查了参与纽约市非处方药注射器计划的药店顾客的药房内艾滋病毒检测。参与者被招募到两家药店完成一项调查，并接受可选的艾滋病毒测试。进行双变量和多变量分析，以检验人口统计学和危险行为与接受药房艾滋病毒检测的相关性。大多数参与者是男性(55%)，黑人(80%)，曾使用过硬性药物(88%)，39.5%接受过药房内艾滋病毒检测。女性(AOR=2.24；95%CI 1.24~4.05)、有多性伴(AOR=1.20；95%CI 1.06~1.35)、12个月前有过HIV检测(AOS=4.06；CI 1.85~8.91)、最近3个月注射毒品(AOR=2.73；95%CI 1.31~5.69)和持续护理(AOR=0.32；95%CI 0.17~0.58)与接受药房HIV检测有关。这些数据为艾滋病毒高危人群提供了药房内艾滋病毒检测的证据。在药房进行艾滋病毒检测可能会补充现有的战略。
Blacks/Hispanics face limited access to HIV testing. We examined in-pharmacy HIV testing among customers in pharmacies participating in a nonprescription syringe program in New York City. Participants were recruited in two pharmacies to complete a survey and receive an optional HIV test. Bivariate and multivariable analyses were performed to examine associations of demographics and risk behaviors with receiving in-pharmacy HIV testing. Most participants were male (55%), black (80%), had used hard drugs (88%), and 39.5% received in-pharmacy HIV testing. Being female (AOR=2.24; 95%CI 1.24-4.05), having multiple sex partners (AOR=1.20; 95% CI 1.06-1.35), having an HIV test more than 12 months ago (AOS=4.06; CI 1.85-8.91), injecting drugs in last 3 months (AOR=2.73; 95% CI 1.31-5.69) and having continuous care (AOR=0.32; 95% CI 0.17-0.58) were associated with receiving in-pharmacy HIV test. These data provide evidence of in-pharmacy HIV testing reaching persons at risk of HIV. HIV testing in pharmacies may complement existing strategies.